Clinical Trial: 400mcg Sublingual Misoprostol as First Line Treatment
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Introduction of 400mcg Sublingual Misoprostol as First Line Treatment in 11 Health Posts in Three Districts in Senegal
Brief Summary: Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.
Detailed Summary:
Sponsor: Gynuity Health Projects
Current Primary Outcome: complete abortion [ Time Frame: 1 year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Gynuity Health Projects
Dates:
Date Received: August 7, 2013
Date Started: September 2011
Date Completion:
Last Updated: September 6, 2013
Last Verified: September 2013